about
Systematic review: the association between eosinophilic oesophagitis and coeliac diseaseGuidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.Efficacy of Dietary Treatment for Inducing Disease Remission in Eosinophilic Gastroenteritis.Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis.Validity and Reliability of Administrative Coded Data for the Identification of Hospital-Acquired Infections: An Updated Systematic Review with Meta-Analysis and Meta-Regression Analysis.Treatment of eosinophilic esophagitis: how should we manage the disease?Eosinophilic gastroenteritis: an update.Systematic review and meta-analysis of performance of second-trimester nasal bone assessment in detection of fetuses with Down syndrome.Dietary therapies for eosinophilic esophagitis.Systematic review of the clinical prediction rules for the calculation of the risk of Down syndrome based on ultrasound findings in the second trimester of pregnancy.Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis.Second-trimester fetal aberrant right subclavian artery: original study, systematic review and meta-analysis of performance in detection of Down syndrome.Treatment of adult eosinophilic esophagitis with diet.Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis.Association between atopic manifestations and eosinophilic esophagitis: A systematic review and meta-analysis.Seasonal distribution of initial diagnosis and clinical recrudescence of eosinophilic esophagitis: a systematic review and meta-analysis.Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies.Systematic review: health-related quality of life in children and adults with eosinophilic oesophagitis-instruments for measurement and determinant factors.Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders.The Use of the Fracture Risk Assessment (FRAX®) Tool in Predicting Risk of Fractures in Patients With Inflammatory Bowel Disease: A Systematic Review.Anemia at the time of diagnosis of inflammatory bowel disease: Prevalence and associated factors in adolescent and adult patients.Update on dietary therapy for eosinophilic esophagitis in children and adults.Quality assessment of clinical practice guidelines for eosinophilic esophagitis using the AGREE II instrument.Meta-analysis of validity of echogenic intracardiac foci for calculating the risk of Down syndrome in the second trimester of pregnancy.Prevalence of eosinophilic oesophagitis in adult patients in a central region of Spain.Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease.Tolerance of a cow's milk-based hydrolyzed formula in patients with eosinophilic esophagitis triggered by milk.Propofol administration is safe in adult eosinophilic esophagitis patients sensitized to egg, soy, or peanut.Same-day bidirectional endoscopy with nonanesthesiologist administration of propofol: safety and cost-effectiveness compared with separated exams.Dietary treatment modulates mast cell phenotype, density, and activity in adult eosinophilic oesophagitis.The role of endoscopy in eosinophilic esophagitis: from diagnosis to therapy.Diagnostic and therapeutic management of eosinophilic oesophagitis in children and adults: results from a Spanish registry of clinical practice.Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.Successful food elimination therapy in adult eosinophilic esophagitis: not all patients are the sameMontelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitisAdult patients with eosinophilic esophagitis do not show an increased frequency of the HLA-DQ2/DQ8 genotypes predisposing to celiac diseaseFour-food group elimination diet for adult eosinophilic esophagitis: A prospective multicenter studySerum IgE-targeted elimination diets for treating eosinophilic esophagitis: things are not what they seemEpidemiology and temporal trends (2000-2012) of inflammatory bowel disease in adult patients in a central region of SpainDual response to dietary/topical steroid and proton pump inhibitor therapy in adult patients with eosinophilic esophagitis
P50
Q26863768-F800851B-B7A0-42DA-9365-8E61D6B24745Q30234446-32D5FF50-A32F-45F1-8383-41C6DBFDC4DFQ34463796-E7C93551-3AA6-4100-A953-C90D5380DC93Q34488489-2516A38B-57B9-4009-8E03-127C4E3A74E6Q36342821-DBD09CC4-CDAD-44AF-B7C1-CB9143277511Q37788511-0EDF2C5F-940D-4A2C-8A33-773DCF571026Q38051704-BC0B6299-9A41-4982-9EF2-C700716C8919Q38154860-BBF43A4C-99F4-408A-B4F3-9D5C02759F37Q38162896-1266A7F8-5E88-44E9-A184-E9130013091FQ38178203-FBFB7932-713D-457E-8642-67F58C07A1C3Q38188754-8B399E3F-D320-458C-9B39-1DC1001F9627Q38192551-045A57C0-2B54-480D-95B0-3BB2384862A7Q38194021-B05D30EB-23A0-46AB-9DBE-120C0E6BDE37Q38248758-F52CBE8D-0941-4512-ABC5-9AD810AE12E2Q38378673-73BC50FE-A972-4FC4-A076-A24BD610CFBCQ38590720-485ECFD9-C5EA-4D2D-993E-C476AD44CB7FQ38618644-F6CB1817-BB7C-4443-9473-A5CCB2DEA1BCQ38714333-833FC766-B6C7-4E91-BF23-1BDF9A7943DAQ38749365-61190EBF-6093-45F8-B0AA-25729A5C69BCQ38950935-F801C94D-DAE7-4157-8E0B-E08FA9F1CE67Q39016319-7BB591C0-C7B6-4022-A137-9D460BA115A1Q39044778-C6FFF819-F7CB-4632-A288-E8CCE3086BA0Q39100795-DA9F5461-489E-4E73-9C29-D0EE1CF28840Q39158560-61FD91FE-F20A-4671-A599-2E04AA07EA5DQ43488960-8A9514BC-9072-4E50-83C4-394D8F5A193FQ45811536-FE67D68F-C2B6-4F78-84A9-65C7DACF77C6Q46898580-186AD6D7-D060-4422-832E-A4359CD8BF6FQ47921956-50DA0A1D-4A8E-4EDB-9E82-7EC69AF7605CQ47933202-7DDD2DAF-5CE0-4114-82FE-5C66BDB46D3AQ48230299-4408E68A-CA1F-4D7E-976C-4DEC39E3E226Q48248127-F5A97CA2-0DBD-45CE-AAFF-7854213FE3E2Q51267822-5D74DDF8-9412-421F-8D68-5A72471EB729Q54351284-2EAF407E-D8C3-493C-AAFB-4AFDF8F83FC0Q83447241-64BEBD11-AB01-4678-AD36-FCF4BCA97963Q84364243-109DC5D3-AB9D-4145-8430-FBAFCF2A71D9Q84776055-8A0136DD-8977-43D3-AC08-4E07D6B0A052Q85222740-8B084045-7AAB-4474-89F5-6A4B4B74CAA1Q85691007-F8965F0B-D299-45AE-AD8B-3BADCE98921AQ85847556-CAF9783F-4DBE-4668-88B9-FE9627B6A859Q86158867-C9FE267F-8044-4425-91EE-95BC4B8ED3FF
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Angel Arias
@en
Angel Arias
@nl
type
label
Angel Arias
@en
Angel Arias
@nl
prefLabel
Angel Arias
@en
Angel Arias
@nl
P31
P496
0000-0003-1006-0958